Matthias Bodenstedt - Net Worth and Insider Trading
Matthias Bodenstedt Net Worth
The estimated net worth of Matthias Bodenstedt is at least $28 Million dollars as of 2024-12-27. Matthias Bodenstedt is the CFO of MoonLake Immunotherapeutics and owns about 520,903 shares of MoonLake Immunotherapeutics (MLTX) stock worth over $28 Million. Details can be seen in Matthias Bodenstedt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthias Bodenstedt has not made any transactions after 2023-12-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthias Bodenstedt
Matthias Bodenstedt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthias Bodenstedt owns 1 companies in total, including MoonLake Immunotherapeutics (MLTX) .
Click here to see the complete history of Matthias Bodenstedt’s form 4 insider trades.
Insider Ownership Summary of Matthias Bodenstedt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | 2023-12-20 | Chief Financial Officer |
Matthias Bodenstedt Latest Holdings Summary
Matthias Bodenstedt currently owns a total of 1 stock. Matthias Bodenstedt owns 520,903 shares of MoonLake Immunotherapeutics (MLTX) as of December 20, 2023, with a value of $28 Million.
Latest Holdings of Matthias Bodenstedt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | 2023-12-20 | 520,903 | 54.40 | 28,337,123 |
Holding Weightings of Matthias Bodenstedt
Matthias Bodenstedt Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthias Bodenstedt has made a total of 1 transactions in MoonLake Immunotherapeutics (MLTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in MoonLake Immunotherapeutics is the sale of 100,000 shares on December 20, 2023, which brought Matthias Bodenstedt around $6 Million.
Insider Trading History of Matthias Bodenstedt
- 1
Matthias Bodenstedt Trading Performance
Matthias Bodenstedt Ownership Network
Matthias Bodenstedt Owned Company Details
What does MoonLake Immunotherapeutics do?
Who are the key executives at MoonLake Immunotherapeutics?
Matthias Bodenstedt is the Chief Financial Officer of MoonLake Immunotherapeutics. Other key executives at MoonLake Immunotherapeutics include director & 10 percent owner Biotechnology Value Fund L P , director & Chief Executive Officer Santos Da Silva Jorge , and Chief Scientific Officer Kristian Reich .
MoonLake Immunotherapeutics (MLTX) Insider Trades Summary
Over the past 18 months, Matthias Bodenstedt made 1 insider transaction in MoonLake Immunotherapeutics (MLTX) with a net sale of 100,000. Other recent insider transactions involving MoonLake Immunotherapeutics (MLTX) include a net sale of 200,000 shares made by Kristian Reich , a net sale of 184,740 shares made by Santos Da Silva Jorge , and a net purchase of 352,051 shares made by Bihua Chen .
In summary, during the past 3 months, insiders sold 2,171,000 shares of MoonLake Immunotherapeutics (MLTX) in total and bought 0 shares, with a net sale of 2,171,000 shares. During the past 18 months, 2,655,740 shares of MoonLake Immunotherapeutics (MLTX) were sold and 352,051 shares were bought by its insiders, resulting in a net sale of 2,303,689 shares.
MoonLake Immunotherapeutics (MLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
MoonLake Immunotherapeutics Insider Transactions
Matthias Bodenstedt Mailing Address
Above is the net worth, insider trading, and ownership report for Matthias Bodenstedt. You might contact Matthias Bodenstedt via mailing address: Dorfstrasse 29, Zug V8 6300.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
